Microba will work with Anatara to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D.
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Using the NEW1000 Family Study, researchers will investigate the role of the microbiome in the developmental origins of health and disease.
A/Prof Lutz Krause and Dr David Wood discuss practical applications of metagenomics in microbiome discovery at ASM's Annual Scientific Meeting.
Microba Life Sciences has united with Illumina, Inc. to advance understanding of the human gut microbiome in human health and disease.
Microba Life Sciences, is empowering global consumer goods company Unilever to explore links between sleep and the human gut.
The partnership's first clinical trial will determine if a new treatment can restore beneficial gut microbiome species and improve symptoms.
Bringing Microba’s world-leading metagenomic sequencing and bioinformatics together with Holobiome’s promising microbiome therapeutic pipeline.
Research study at Curtin University examining possible links between infant gut microbiome composition and the development of allergies.
Microba have partnered with the Microbiome Research Centre (MRC) to power new gut microbiome research.